Shandong Xinhua Pharmaceutical Co Ltd banner

Wall St Price Targets

SHNXY Price Forecast
Based on 3 analysts

-28% Downside
from $18.19 today

Shandong Xinhua Pharmaceutical Co Ltd (SHNXY)’s 12-month stock price forecast through October 2027 has a consensus target of $13.13, implying 28% downside. The forecast is based on price targets from 3 Wall Street analysts.

SHNXY Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for SHNXY yet.

Shandong Xinhua Pharmaceutical Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SHNXY's stock price target?
Price Target
13.13 USD

According to Wall Street analysts, the average 1-year price target for SHNXY is 13.13 USD with a low forecast of 13 USD and a high forecast of 13.51 USD.

What is the Revenue forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 2 years is 2%.

What is the Operating Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 2 years is 25%.

What is the Pre-Tax Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
36%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 2 years is 36%.

What is the Net Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
40%

Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 2 years is 40%.

Back to Top